Fengmin Shao
- Molecular Biology
- Cancer Research
- Nephrology top 10%
- Pulmonary and Respiratory Medicine
- Infectious Diseases
- Co-authors
- Lei YanYue GuRick F. ThorneMian WuXu Dong ZhangHuixia CaoLirong ZhangJianqin Gu
- Topics
- COVID-19 Clinical Research Studies (5 papers)Renal cell carcinoma treatment (4 papers)Chronic Kidney Disease and Diabetes (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fengmin Shao
32 papers receiving 468 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 183
- Cancer Research 95
- Nephrology 72
- Pulmonary and Respiratory Medicine 65
- Infectious Diseases 58
Countries citing papers authored by Fengmin Shao
This map shows the geographic impact of Fengmin Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengmin Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengmin Shao more than expected).
Fields of papers citing papers by Fengmin Shao
This network shows the impact of papers produced by Fengmin Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengmin Shao. The network helps show where Fengmin Shao may publish in the future.
Co-authorship network of co-authors of Fengmin Shao
This figure shows the co-authorship network connecting the top 25 collaborators of Fengmin Shao. A scholar is included among the top collaborators of Fengmin Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengmin Shao. Fengmin Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 66 | |
| 10 | 27 | |
| 11 | 20 | |
| 12 | 25 | |
| 13 | 41 | |
| 14 | 13 | |
| 15 | 16 | |
| 16 | 8 | |
| 17 | 8 | |
| 18 | 18 | |
| 19 | 5 | |
| 20 | 11 |
About Fengmin Shao
Fengmin Shao is a scholar working on Nephrology, Cancer Research and Infectious Diseases, having authored 36 papers that have together received 471 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Renal cell carcinoma treatment (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Nephrology (72 citations), Cancer Research (95 citations) and Infectious Diseases (58 citations). Fengmin Shao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lei Yan, Yue Gu, Rick F. Thorne, Mian Wu, Xu Dong Zhang, Huixia Cao, Lirong Zhang, Jianqin Gu, Jinming Li and Ruijie Wang. Their work appears in journals such as JAMA, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.